In a significant shift for international trade and healthcare policy, the United States and the United Kingdom have formally concluded a bilateral arrangement aimed at restructuring pharmaceutical pricing mechanisms between the two nations. Announced in Washington on April 2, 2026, the agreement represents a collaborative effort by United States Trade Representative Jamieson Greer, Health and […]